Literature DB >> 27618338

Structural and mechanistic insights into human splicing factor SF3b complex derived using an integrated approach guided by the cryo-EM density maps.

Ramachandran Rakesh1, Agnel Praveen Joseph2, Ramachandra M Bhaskara1,2, Narayanaswamy Srinivasan1.   

Abstract

Pre-mRNA splicing in eukaryotes is performed by the spliceosome, a highly complex macromolecular machine. SF3b is a multi-protein complex which recognizes the branch point adenosine of pre-mRNA as part of a larger U2 snRNP or U11/U12 di-snRNP in the dynamic spliceosome machinery. Although a cryo-EM map is available for human SF3b complex, the structure and relative spatial arrangement of all components in the complex are not yet known. We have recognized folds of domains in various proteins in the assembly and generated comparative models. Using an integrative approach involving structural and other experimental data, guided by the available cryo-EM density map, we deciphered a pseudo-atomic model of the closed form of SF3b which is found to be a "fuzzy complex" with highly flexible components and multiplicity of folds. Further, the model provides structural information for 5 proteins (SF3b10, SF3b155, SF3b145, SF3b130 and SF3b14b) and localization information for 4 proteins (SF3b10, SF3b145, SF3b130 and SF3b14b) in the assembly for the first time. Integration of this model with the available U11/U12 di-snRNP cryo-EM map enabled elucidation of an open form. This now provides new insights on the mechanistic features involved in the transition between closed and open forms pivoted by a hinge region in the SF3b155 protein that also harbors cancer causing mutations. Moreover, the open form guided model of the 5' end of U12 snRNA, which includes the branch point duplex, shows that the architecture of SF3b acts as a scaffold for U12 snRNA: pre-mRNA branch point duplex formation with potential implications for branch point adenosine recognition fidelity.

Entities:  

Keywords:  Cryo-EM; SF3b complex; U11/U12 di-snRNP; integrative structure modeling; spliceosome

Mesh:

Substances:

Year:  2016        PMID: 27618338      PMCID: PMC5056777          DOI: 10.1080/15476286.2016.1218590

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  123 in total

1.  Three-dimensional structure of a pre-catalytic human spliceosomal complex B.

Authors:  Daniel Boehringer; Evgeny M Makarov; Bjoern Sander; Olga V Makarova; Berthold Kastner; Reinhard Lührmann; Holger Stark
Journal:  Nat Struct Mol Biol       Date:  2004-04-18       Impact factor: 15.369

2.  Dynamic protein-protein interaction wiring of the human spliceosome.

Authors:  Anna Hegele; Atanas Kamburov; Arndt Grossmann; Chrysovalantis Sourlis; Sylvia Wowro; Mareike Weimann; Cindy L Will; Vlad Pena; Reinhard Lührmann; Ulrich Stelzl
Journal:  Mol Cell       Date:  2012-02-24       Impact factor: 17.970

Review 3.  Cryo-electron microscopy of spliceosomal components.

Authors:  Holger Stark; Reinhard Lührmann
Journal:  Annu Rev Biophys Biomol Struct       Date:  2006

4.  Composition and three-dimensional EM structure of double affinity-purified, human prespliceosomal A complexes.

Authors:  Nastaran Behzadnia; Monika M Golas; Klaus Hartmuth; Bjoern Sander; Berthold Kastner; Jochen Deckert; Prakash Dube; Cindy L Will; Henning Urlaub; Holger Stark; Reinhard Lührmann
Journal:  EMBO J       Date:  2007-03-01       Impact factor: 11.598

Review 5.  Macromolecular modeling with rosetta.

Authors:  Rhiju Das; David Baker
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

Review 6.  Spliceosome structure and function.

Authors:  Cindy L Will; Reinhard Lührmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

7.  The anti-tumor drug E7107 reveals an essential role for SF3b in remodeling U2 snRNP to expose the branch point-binding region.

Authors:  Eric G Folco; Kaitlyn E Coil; Robin Reed
Journal:  Genes Dev       Date:  2011-03-01       Impact factor: 11.361

8.  Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A.

Authors:  Anna Corrionero; Belén Miñana; Juan Valcárcel
Journal:  Genes Dev       Date:  2011-03-01       Impact factor: 11.361

9.  Splicing factor SF3b as a target of the antitumor natural product pladienolide.

Authors:  Yoshihiko Kotake; Koji Sagane; Takashi Owa; Yuko Mimori-Kiyosue; Hajime Shimizu; Mai Uesugi; Yasushi Ishihama; Masao Iwata; Yoshiharu Mizui
Journal:  Nat Chem Biol       Date:  2007-07-22       Impact factor: 15.040

Review 10.  The spliceosome: disorder and dynamics defined.

Authors:  Weijun Chen; Melissa J Moore
Journal:  Curr Opin Struct Biol       Date:  2014-02-14       Impact factor: 6.809

View more
  3 in total

Review 1.  A Challenging Pie to Splice: Drugging the Spliceosome.

Authors:  Brian León; Manoj K Kashyap; Warren C Chan; Kelsey A Krug; Januario E Castro; James J La Clair; Michael D Burkart
Journal:  Angew Chem Int Ed Engl       Date:  2017-08-15       Impact factor: 15.336

2.  SF3b1 mutations associated with myelodysplastic syndromes alter the fidelity of branchsite selection in yeast.

Authors:  Tucker J Carrocci; Douglas M Zoerner; Joshua C Paulson; Aaron A Hoskins
Journal:  Nucleic Acids Res       Date:  2017-05-05       Impact factor: 16.971

3.  Srinivasan (1962-2021) in Bioinformatics and beyond.

Authors:  M Michael Gromiha; Christine Orengo; Ramanathan Sowdhamini; Janet Thornton
Journal:  Bioinformatics       Date:  2022-02-03       Impact factor: 6.937

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.